Header Logo

Connection

Richard Lirio to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Richard Lirio has written about Drug Administration Schedule.
Richard Lirio
Connection Strength
0.045
Drug Administration Schedule
  1. Wyant T, Yang L, Lirio RA, Rosario M. Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease. J Clin Pharmacol. 2021 09; 61(9):1174-1181.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.